European Journal of Radiology
Volume 54, Issue 1 , Pages 148-155 , April 2005

The value of contrast enhanced power Doppler ultrasonography in differentiating hypoehoic lesions in the peripheral zone of prostate

  • Can Zafer Karaman

      Affiliations

    • Department of Radiology 09100, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey
    • Corresponding Author InformationCorresponding author. Tel.: +90 256 2120 020/221; fax: +90 256 212 6399.
  • ,
  • Alparslan Ünsal

      Affiliations

    • Department of Radiology 09100, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey
  • ,
  • Alev Akdilli

      Affiliations

    • Department of Radiology 09100, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey
  • ,
  • Füsun Taşkın

      Affiliations

    • Department of Radiology 09100, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey
  • ,
  • Haluk Erol

      Affiliations

    • Department of Urology 09100, Faculty of Medicine, Adnan Menderes University, Aydin, Turkey

Received 6 November 2003 ,Revised 14 April 2004 ,Accepted 19 April 2004.

References 

  1. Jemal A, Murray T, Samuels A, et al.  Cancer statistics 2003. CA Cancer J Clin. 2003;53:5–26
  2. Rifkin MD, Choi H. Implications of small, peripheral hypoechoic lesions in endorectal US of the prostate. Radiology. 1988;166:619–622
  3. Lee F, Littrup PJ, Torp-Pedersen S, et al.  Screening for prostate cancer: comparison of transrectal ultrasound and the digital rectal examination. Radiology. 1988;168:389–394
  4. Clements R. Ultrasound of prostate cancer. Eur Radiol. 2001;11:2119–2125
  5. Chodak GW, Wald V, Parmer E, et al.  Comparison of digital rectal examination and transrectal ultrasonography for the diagnosis of prostatic cancer. J Urol. 1986;135:951–954
  6. Lee F, Torp-Pedersen ST, Siders DB, et al.  Transrectal ultrasound in the diagnosis and staging of prostatic carcinoma. Radiology. 1989;170:609–615
  7. Oyen R, Van Poppel H, Vandevoorde W. The significance of focal hypoechoic lesions in the peripheral zone of the prostate. J Belge Radiol. 1995;78:356–358
  8. Sibley RI, Sibley AF. Correlation of digital rectal examination, prostate specific antigen and transrectal ultrasound in prostate carcinoma in African Americans. J Natl Med Assoc. 1997;89:318–323
  9. Norberg M, Egevad L, Holmberg L, et al.  The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology. 1997;50:562–566
  10. Collin GN, Lloyd SN, Hekir M, et al.  Multiple transrectal ultrasound-guided biopsies–true morbidity and patient acceptance. Br J Urol. 1993;71:460–463
  11. Rodriguez LV, Terris MK. Risks and complications of transrectal ultrasound guided prostate needle biopsy: A prospective study and review of the literature. J Urol. 1998;160:2115–2120
  12. Newman JS, Bree RL, Rubin JM. Prostate cancer: diagnosis with colour Doppler sonography with histologic correlation of each biopsy site. Radiology. 1995;195:86–90
  13. Cornud F, Belin X, Piron D. Color Doppler guided prostate biopsies in 591 patients with an elevated serum PSA level: Impact on gleason score for nonpalpable lesions. Urology. 1997;49:709–715
  14. Cho JY, Kim SH, Lee SE. Peripheral hypoechoic lesions of the prostate: Evaluation with color and power Doppler ultrasound. Eur Urol. 2000;37:443–448
  15. Takahashi S, Yamada Y, Homma Y. Power Doppler ultrasonography-directed prostate biopsy in men with elevated serum PSA levels. Adult Urol. 2002;60:248–252
  16. Sakarya ME, Arslan H, Unal O, et al.  The role of power Doppler US in the diagnosis of prostate cancer: a preliminary study. BJU. 1998;82:186–188
  17. Kelly IMG, Leea WR, Rickards D. Prostate cancer and the role of color Doppler US. Radiology. 1993;189:153–156
  18. Rubin JM, Bude R. Power Doppler US: a potential useful alternative to mean frequency-based color Doppler US. Radiology. 1994;190:853–856
  19. Louva E, Littrup PJ. Correlation of color Doppler flow in the prostate with tissue microvascularity. Cancer. 1998;83:135–140
  20. Strohmeyer D, Frauscher F, Klauser A. Contrast-enhanced transrectal color Doppler ultrasonography for assessment of angiogenesis in prostate cancer. Anticancer Research. 2001;21:2907–2914
  21. Cosgrove D. Echo enhancers ‘contrast’ agents for ultrasound. BMUS Bull 1994; 3, (No. 1).
  22. Cosgrove D. Why do we need contrast agents for ultrasound?. Clin Radiol. 1996;51:1–4
  23. Frinking PJ, Bouakaz A, Kirkhorn J, et al.  Ultrasound contrast imaging. Ultrasound in Med & Biol. 2000;26:965–975
  24. Ragde H, Kenny G, Murphy GP, Landin K. Transrectal ultrasound microbubble contrast angiography of the prostate. Prostate. 1997;32:279–283
  25. Bogers H, Sedelaar JPM, Beerlage HP, et al.  Contrast-enhanced three dimensional power Doppler angiography of the human prostate: correlation with the biopsy outcome. Adult Urol. 1999;54:97–104
  26. Frauscher F, Klauser A, Halpern EJ, et al.  Detection of prostate cancer with a microbubble ultrasound contrast agent. Lancet. 2001;357:1849–1850
  27. Sedelaar JPM, van Leenders GJLH, van de Ka CAH, et al.  Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer. Eur Urol. 2001;40:285–293
  28. Halpern EJ, Rosenberg M, Gomella LG. Prostate cancer: contrast enhancer US for detection. Radiology. 2001;219:219–225
  29. Frauscher F, Klause A, Volgger H, et al.  Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol. 2002;167:1648–1652
  30. Halpern EJ, Frauscher F, Rosenberg M, Gomella LG. Directed biopsy during contrast enhanced sonography of the prostate. AJR. 2002;178:915–919
  31. Rifkin MD, McGlynn ET, Choi H. Echogenicity of prostate cancer correlated with histologic grade and stromal fibrosis: Endorectal US studies. Radiology. 1989;170:549–552
  32. Lee F, Torp-Pedersen S, Littrup PJ, et al.  Hypoechoic lesions of the prostate: Clinical relevance of tumor size, digital rectal examination and prostate specific antigen. Radiology. 1989;170:29–32
  33. Keetch DW, Catalona WJ, Smith DS. Serial prostatic biopsies in men with persistently elevated serum prostate specific antigen values. J Urol. 1994;151:1571–1574
  34. Ellis WJ, Brawer MK. Repeat prostate needle biopsy: who needs it?. J Urol. 1995;153:1496–1498
  35. Roehrborn CG, Pickens GJ, Sanders JS. Diagnostic yield of repeated transrectal ultrasound-guided biopsies stratified by specific histopathologic diagnoses and prostate specific antigen levels. Urology. 1996;47:347–352
  36. Stroumbakis N, Cookson MS, Reuter VE, Fair WR. Clinical significance of repeat sextant biopsies in prostate cancer patients. Urology. 1997;49(Suppl 3A):113–118
  37. Burns PN, Hilpert P, Goldberg BB. Intravenous contrast agent for ultrasound Doppler: in vivo measurement of small vessel dose response. IEEE Eng Med Biol Soc. 1990;12:322–324
  38. Bertolotto M, Dalla Palma L, Quaia E, Locatelli M. Characterization of unifocal liver lesions with pulse inversion harmonic imaging after Levovist injection. Eur Radiol. 2000;10:1369–1376
  39. Stroebel D, Hoefer A, Martus P, et al.  Dynamic contrast enhanced power Doppler sonography improves the differential diagnosis of liver lesions. Int J Colorectal Dis. 2001;16:247–256
  40. Raza S, Baum JK. Solid breast lesions: evaluation with power Doppler US. Radiology. 1997;203:164–168
  41. Akdilli A, Karaman CZ, Erkuş M, Ünsal A. Supplemetary diagnostic value of power Doppler ultrasonography in the assessment of solid breast lesions. Turk J Diagn Intervent Radiol. 1999;5:292–296
  42. Karaman GC, Karaman CZ, Sendur N, et al.  Power Doppler ultrasonography for the evaluation of skin tumors other than malignant melanoma. Eur Radiol. 2001;11:1111–1116

 This study had been presented at the ‘Scientific Sessions’ of the ECR 2003.

PII: S0720-048X(04)00153-6

doi: 10.1016/j.ejrad.2004.04.013

European Journal of Radiology
Volume 54, Issue 1 , Pages 148-155 , April 2005